Breaking News

ICON, Mereo In Exclusive Clinical Services Pact

ICON will serve as sole provider of clinical development services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ICON plc has partnered with Mereo BioPharma Group, a specialty biopharma company, under which ICON will be the sole provider of clinical development services.   Mereo, based in the UK, is focused on acquiring, developing and commercializing innovative medicines to treat rare and specialized disease areas. The company’s initial portfolio consists of clinical-stage products acquired from Novartis to treat brittle bone syndrome, acute exacerbations of chronic obstructive pulmonary disease, and hy...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters